Loading...
Price Table
* Prices are based on daily market changes.
DateOpenHighLowCloseVolumeDelivery %20-Day sma50-Day sma200-Day sma
Day High Low Range
TimeLowesthighestVolume
Past Performance & Moving Averages
Day’sLow high rangeSMAStock performanceNifty performance
PIVOT POINTS
NAMES4S3S2S1PIVOT POINTSR1R2R3R4
CLASSIC---------
WOODIE‘S----
FIBONACCI--
CAMARILLA-
Trend Analysis
Key Data
Market capBook valuestock p/eDividend yieldroceroesales growth (3Y)face value (3Y)
Profile

IPCALAB

In 1949, Ipca Laboratories Limited, which is a pharmaceutical company, was being incorporated. It was also promoted by a group of medical businessmen and professionals who were incorporated under the brand name 'The Indian Pharmaceutical Combine Association.' It is also a fully backward integrated, Indian pharmaceutical company with a robust thrust on exports. It is also the largest manufacturers of several APIs that they produce right from the primary stage. Both the APIs and Formulations are produced at the world-class manufacturing facilities. Leading drug regulatory authorities have approved these facilities - MHRA UK, US FDA, TGA Australia, WHO Geneva, HPFB Canada, WHO Geneva, MCC South Africa, PMDA Japan, KFDA Korea, EDQM and LAGeSO Berlin MOH. Currently, it is therapy leaders in both antimalarial as well as rheumatoid arthritis in the Indian market, along with a fast expanding presence in the global market as well. It has a brand leadership in 4-5 therapeutic areas, for both the Formulations and APIs. Also, four of their major branded Formulations were ranked among the top 300 brands of India, and soon it emerged as one among the top exporters of APIs worldwide. It is also one of the biggest manufacturers in the world of APIs, and to name a few - Atenolol (Antihypertensive), Furosemide (Diuretic), Pyrantel Salts (Anthelmintic), Hydroxy Chloroquine Sulphate (NSAID), Chloroquine Phosphate (Antimalarial), Metoprolol Tartrate & Succinate (Antihypertensives). The Company is the largest supplier of such APIs and their intermediates world over. Their top 10 formulation brands are Zerodol (Aceclofenac and Combinations), Lariago (Chloroquine), HCQS (Hydroxychloroquine), Perinorm (Metoclopramide), Rapither (Artemotil), Tenoric (Chlorthalidone + Atenolol), Lumerax (Artemether + Lumefantrine), Etova (Etodolac), Malirid (Primaquine) and Folitrax (Methotrexate). With operations in over 110 countries across the globe, exports and domestic business account for the equal contribution of the company's income. Forbes, which is a leading US business magazine, selected Ipca in 2003, 2004, 2005 and 2007 among its top 200 successful, rising companies overseas, along with the sales under $1 Billion. Amongst several other Indian companies, only a few Indian Pharmaceutical companies are being featured in the Forbes list, and Ipca is one of them. It has also been awarded as 'Among the 100 Best Companies to Work in India' during the survey conducted for the 'India's Best Companies to Work For-2010'.

Some of the Group Companies:

Tonira
  • Tonira - Ankleshwar
  • Tonira - Nandesari

Some of the Products:

  1. APIs:It manufactures internationally known APIs, namely Atenolol (Antihypertensive), Chloroquine Phosphate (Antimalarial), Furosemide (Diuretic) and Pyrantel Salts (Anthelmintic). It also manufactures a range of drugs Intermediates.
  2. Formulations:It manufactures over 150 formulations catering in therapeutic and generic segments. These dosage forms are manufactured in tablets, capsules, oral liquids, dry powders for suspension, and injectable (liquid and dry).

Some of the Milestones:

  • 1976: It started the marketing of sugarcoated Chloroquine tablets, which was the first time in India.
  • 1978:
  • It introduced the formulations of Metoclopramide under the brand name 'Perinorm' for the first time in India.
  • It introduced 'Ipca Contact,' company's in-house Magazine.
  • 1994:
  • The Maiden Public Issue of shares.
  • It acquired an API manufacturing plant from BDH Pharmaceuticals (which is a subsidiary of E–Merck) located at Indore.
  • 1995: It commissioned a modern fo